Related Experiment Video
Updated: Jul 23, 2026

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors
Published on: April 9, 2014
Optimal treatment of nevirapine-associated hepatotoxicity remains uncertain
D Bundow1, L Rosoff, D M Aboulafia
1Division of Gastroenterology, Virginia Mason Medical Center, Seattle, USA.
Abstract:
The cases of 2 patients with nevirapine-associated hepatotoxicity in conjunction with rash and eosinophilia are reported here. Both patients' conditions improved following withdrawal of nevirapine. Previous case reports have described a variety of interventions other than drug withdrawal that might have contributed to resolution of drug-induced hepatitis. Until a better understanding of the clinical spectrum and pathophysiology of nevirapine-associated hepatotoxicity is realized, treatment will remain largely empiric.
Related Concept Videos
Hepatic Drug Excretion: Influencing Factors
Pharmacokinetics in Pediatric Patients: Drug Excretion
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
Pharmaceutical Poisoning: Treatment Strategies
Antiviral Nucleoside Inhibitors

